RUZURGI

medunik canada🇨🇦 Health Canada

Approval Id: 109f33076c3bc852
Drug Approval Canada Name: RUZURGI
Product Name: RUZURGI
Status: Marketed
Status Date: 2023-01-24
Original Market Date: 2020-09-24
Din: 02503034
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:92.00
Atc Original: N07XX05 AMIFAMPRIDINE
Atc Name: n 07 xx 05
Aig Number: 0162417001
Company Name: medunik canada
Company Address: 950 Michèle-Bohec Blvd., Blainville, Quebec, Canada, J7C 5E2

AMIFAMPRIDINE

10 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

109f33076c3bc852

Type

Standard